Glaukos (GKOS) Capital Expenditures Growth (3y) (2017 - 2026)
Glaukos (GKOS) Capital Expenditures Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.08% |
| 10 | Glaukos | 7.55 Bn | 7.45 Bn | 117.23 Mn | -16.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.94% |
| Dec 31, 2025 | 38.38% |
| Sep 30, 2025 | -58.25% |
| Jun 30, 2025 | 19.65% |
| Mar 31, 2025 | -57.64% |
| Dec 31, 2024 | -66.36% |
| Sep 30, 2024 | 27.14% |
| Jun 30, 2024 | -55.69% |
| Mar 31, 2024 | -36.87% |
| Dec 31, 2023 | -42.13% |
| Sep 30, 2023 | -111.01% |
| Jun 30, 2023 | 28.35% |
| Mar 31, 2023 | 106.72% |
| Dec 31, 2022 | -158.54% |
| Sep 30, 2022 | 81.68% |
| Jun 30, 2022 | 71.25% |
| Mar 31, 2022 | 116.48% |
| Dec 31, 2021 | 81.78% |
| Sep 30, 2021 | -236.71% |
| Jun 30, 2021 | 219.10% |